AstraZeneca PLC (AZN) is a publicly traded Healthcare sector company. As of August 17, 2026, AZN trades at $156.25 with a market cap of $242.64B and a P/E ratio of 0.00. AZN moved -0.77% today. Year to date, AZN is -14.91%; over the trailing twelve months it is -0.31%. Its 52-week range spans $122.48 to $212.71. Analyst consensus is strong buy with an average price target of $217.69. Rallies surfaces AZN's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies tracks politician and congressional stock disclosures for AZN, including purchases, sales, transaction dates, owners, and reported trade amounts when available.
| Metric | Value |
|---|---|
| Price | $156.25 |
| Market Cap | $242.64B |
| P/E Ratio | 0.00 |
| EPS | $0.00 |
| Dividend Yield | 0.80% |
| 52-Week High | $212.71 |
| 52-Week Low | $122.48 |
| Volume | 3.48M |
| Avg Volume | 0 |
| Revenue (TTM) | $0 |
| Net Income | $0 |
| Gross Margin | 0.00% |
14 analysts cover AZN: 0 strong buy, 12 buy, 1 hold, 1 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $217.69.